Cancer treatment with chemotherapeutic agents is often associated with delayed adverse neurological consequences - an occurrence often referred to as “chemobrain” - that may compromise the quality of life of a proportion of cancer survivors. Now, research published in the open access Journal of Biology demonstrates that treatment with a single chemotherapeutic agent, 5-fluorouracil (5-FU), by itself is sufficient to cause a syndrome of delayed degeneration in the central nervous system (CNS). 5-FU is a widely used chemotherapeutic agent that is employed, alone or in combination with other agents, in the treatment of cancers of the colon, rectum, breast, stomach, pancreas, ovaries and bladder.
Little is known about the side-effects of chemotherapy on the CNS, despite their obvious clinical importance. Until now researchers have not fully understood the underlying biology, including whether these effects require: exposure to multiple chemotherapeutic agents; chemotherapeutic agents plus the body’s own response to cancer; blood-brain barrier damage; or inflammation. Clinicians have also lacked animal models to study this important problem.
Professor Mark Noble and colleagues of the University of Rochester Stem Cell and Regenerative Medicine Institute and the Harvard Medical School, Boston discovered that short-term systemic administration of 5-FU to mice caused both acute CNS damage and a syndrome of progressively worsening delayed damage. This damage was not self-repairing, and instead became worse over time. In addition, Noble and colleagues also demonstrated that treatment with chemotherapy also had delayed effects on the speed with which information is transferred from the ear to the brain.
Myelin sheaths are necessary for normal neuronal function. One key finding of the study was that clinically relevant concentrations of 5-FU were toxic not only for dividing cells of the CNS but also for the cells that produce the insulating myelin sheaths (non-dividing oligodendrocytes). The delayed damage the researchers measured was to the myelinated tracts of the CNS and associated with extensive myelin pathology. The findings regarding the speed of ear-to-brain information transfer may offer a non-invasive means of analyzing myelin damage associated with cancer treatment.
“Multiple clinical reports have identified neurotoxicity as a complication of treatment regimens in which chemotherapeutic agents such as 5-fluorouracil are components,” says Noble. “As treatments with chemotherapeutic agents will clearly remain the standard of care for cancer patients for many years to come, the need to better understand such damage is great.”
Professor Noble continues “These studies extend the field of stem cell medicine beyond the use of cell transplantation for tissue repair. It is our knowledge of stem cell biology that allows us to begin to understand some of the causes of this syndrome, as well as providing the means of preventing or repairing this damage.”
This research provides the first demonstration that delayed CNS damage can be induced by a single chemotherapeutic agent and also generates the first animal model of such damage. These studies further demonstrate that this syndrome differs from that caused by irradiation and thus may represent a new class of delayed CNS degenerative damage.
Notes to Editors:
1. Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the CNS.
Ruolan Han, Yin M. Yang, Joerg Dietrich, Anne Luebke, Margot Mayer-Pröschel and Mark Noble
Journal of Biology (in press)
During embargo, article available here: http://jbiol.com/press/noble.pdf
After the embargo, article available at the journal website: http://jbiol.com/
Please name the journal in any story you write. If you are writing for the web, please link to the article. All articles are available free of charge, according to BioMed Central’s open access policy.
Article citation and URL available on request at press@biomedcentral.com on the day of publication.
2. In an accompanying minireview, Christina Meyers from the MD Anderson Cancer Center in Texas explains the side effects seen in patients treated with chemotherapy and discusses how the researchers’ results contribute to the understanding of the negative effects of chemotherapy which will have potential for the monitoring of patients and the development of future treatments.
How chemotherapy damages the central nervous system
Christina A Meyers
Journal of Biology, (in press)
During embargo, minireview available here: http://jbiol.com/press/meyers.pdf
After the embargo, minireview available at the journal website: http://jbiol.com/
3. Journal of Biology is an international journal that publishes biological research articles of exceptional interest, together with associated commentary. Original research articles that are accepted for publication are published in full on the web within two weeks, are immediately made freely available to all. Articles from the full spectrum of biology are appropriate for consideration, provided they are of outstanding interest and importance.
4. BioMed Central (http://www.biomedcentral.com/) is an independent online publishing house committed to providing immediate access without charge to the peer-reviewed biological and medical research it publishes. This commitment is based on the view that open access to research is essential to the rapid and efficient communication of science.
Journal
Journal of Biology